Physician
ST Anthony Shawnee Hospital INC
ST Anthony Shawnee Hospital INC was paid $23.00M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoST ANTHONY SHAWNEE HOSPITAL INC
SHAWNEE, OK 74804
SHAWNEE, OK 74804
33aNPI1134123193assigned 06/08/2005
33bProvider typeAnesthesiology Physician
28Total paid$23.00M
24GClaims350,643
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Oklahoma
Rank by total paid#1 of 47
Median peer was paid$94K
This provider vs. median244×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MANUEL, SHASTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,679 | $2.03M | |
| 2019 | 35,618 | $2.12M | |
| 2020 | 28,044 | $1.67M | |
| 2021 | 45,185 | $2.57M | |
| 2022 | 72,440 | $4.80M | |
| 2023 | 82,357 | $5.92M | |
| 2024incomplete | 51,320 | $3.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 43,384 | 42,920 | $6.81M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 21,910 | 21,708 | $4.91M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10% | 25,291 | 25,131 | $2.34M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8.0% | 14,461 | 14,273 | $1.84M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.7% | 3,368 | 3,343 | $1.07M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.2% | 9,840 | 9,703 | $725K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.8% | 998 | 642 | $638K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.2% | 153 | 153 | $512K |
| J3490 | Unclassified drugs | 1.9% | 11,238 | 9,021 | $427K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 8,488 | 8,324 | $363K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 5,323 | 5,277 | $242K |
| 80053 | Comprehensive metabolic panel | <1% | 14,281 | 13,991 | $209K |
119 more codes
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,567 | $208K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 8,543 | $200K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,179 | $195K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,996 | $193K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,753 | $189K |
| 87070 | <1% | 19,554 | $147K | |
| 71045 | Radiologic examination, chest; single view | <1% | 11,814 | $145K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,226 | $139K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,969 | $118K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,921 | $107K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,749 | $107K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,396 | $86K |
| S9443 | Lactation classes, non-physician provider, per session | <1% | 866 | $74K |
| 80055 | <1% | 1,244 | $53K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,267 | $51K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 328 | $49K |
| 81025 | <1% | 6,795 | $47K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 758 | $46K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 115 | $45K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,910 | $42K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 634 | $40K |
| 81003 | <1% | 18,079 | $39K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,836 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,510 | $35K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,709 | $35K |
| 87150 | <1% | 997 | $29K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,892 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 841 | $25K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,611 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 840 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,992 | $22K |
| 87653 | <1% | 622 | $20K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 244 | $18K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 117 | $17K |
| 83655 | <1% | 1,440 | $17K | |
| 83690 | <1% | 2,888 | $16K | |
| 99223 | Prolong inpt eval add15 m | <1% | 160 | $16K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 158 | $15K |
| 86787 | <1% | 921 | $13K | |
| 80050 | General health panel | <1% | 435 | $13K |
| 94060 | <1% | 414 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 98 | $11K |
| 87081 | <1% | 1,624 | $11K | |
| 86803 | <1% | 978 | $11K | |
| 84484 | <1% | 665 | $10K | |
| 82950 | <1% | 1,468 | $8K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,453 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 152 | $6K |
| 87807 | <1% | 518 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 83 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 476 | $5K |
| 80306 | <1% | 353 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 28 | $5K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 25 | $5K |
| 99220 | <1% | 44 | $5K | |
| 80061 | Lipid panel | <1% | 493 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 24 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 530 | $4K |
| 83970 | <1% | 96 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 253 | $3K |
| 87428 | <1% | 109 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 39 | $3K |
| 99217 | <1% | 67 | $3K | |
| 00126 | <1% | 18 | $3K | |
| 84439 | <1% | 354 | $3K | |
| 87510 | <1% | 144 | $2K | |
| 87660 | <1% | 144 | $2K | |
| 87480 | <1% | 144 | $2K | |
| 88300 | <1% | 266 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $2K |
| 86762 | <1% | 230 | $2K | |
| 84481 | <1% | 169 | $2K | |
| 86850 | <1% | 301 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 40 | $2K |
| 97597 | <1% | 324 | $2K | |
| 86780 | <1% | 226 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 149 | $1K |
| 85014 | <1% | 669 | $1K | |
| 87340 | <1% | 226 | $1K | |
| 83605 | <1% | 104 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,570 | $1K |
| 80069 | <1% | 157 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 43 | $988.69 |
| 85018 | <1% | 470 | $899.75 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 16 | $776.21 |
| 87075 | <1% | 56 | $729.05 | |
| 94729 | <1% | 14 | $706.58 | |
| 86592 | <1% | 205 | $654.77 | |
| 84156 | <1% | 215 | $612.32 | |
| 82570 | <1% | 126 | $539.27 | |
| 83735 | <1% | 94 | $530.44 | |
| 94727 | <1% | 14 | $529.06 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 501 | $527.12 |
| 85027 | <1% | 92 | $522.35 | |
| 83615 | <1% | 94 | $461.38 | |
| 86900 | <1% | 272 | $444.50 | |
| 86901 | <1% | 272 | $438.90 | |
| 82728 | <1% | 31 | $415.91 | |
| 83880 | <1% | 12 | $384.12 | |
| 84550 | <1% | 113 | $345.60 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,625 | $284.49 |
| 88304 | <1% | 13 | $271.07 | |
| 82248 | <1% | 59 | $259.26 | |
| 82247 | <1% | 58 | $254.79 | |
| 82607 | <1% | 13 | $199.03 | |
| 87147 | <1% | 39 | $192.21 | |
| 87205 | <1% | 56 | $178.60 | |
| 86706 | <1% | 13 | $124.15 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 92 | $89.40 |
| 80076 | <1% | 14 | $77.78 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 25 | $43.85 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 711 | $9.43 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,186 | $0.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 579 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 200 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 53 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 13 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 50 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 342 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANUEL, SHASTA (VP - FINANCE)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Oklahoma, INC. | Oklahoma City, OK | $46.86M |
| Saints Medical Group, LLC | Shawnee, OK | $14.52M |
| Saint Medical Group, LLC | Shawnee, OK | $4.51M |
| SSM Regional Health Services | Jefferson City, MO | $2.49M |
| Saints Medical Group, LLC | Shawnee, OK | $1.32M |
| SSM Regional Health Services | Jefferson City, MO | $1.26M |
| SSM Health Care of Oklahoma, INC. | Oklahoma City, OK | $856K |
| SSM Regional Health Services | Jefferson City, MO | $842K |
| SSM Regional Health Services | Jefferson City, MO | $398K |
| SSM Regional Health Services | Belle, MO | $388K |
| SSM Regional Health Services | Tipton, MO | $304K |
| SSM Health Care of Oklahoma, INC | Oklahoma City, OK | $269K |
| Saint Medical Group, LLC | Tecumseh, OK | $246K |
| SSM Regional Health Services | Jefferson City, MO | $239K |
| Saint Medical Group, LLC | Chandler, OK | $194K |
| SSM Regional Health Services | Jefferson City, MO | $191K |
| Saints Medical Group, LLC | Okemah, OK | $165K |
| SSM Regional Health Services | Jefferson City, MO | $149K |
| Saints Medical Group, LLC | Oklahoma City, OK | $84K |
| SSM Regional Health Services | Jefferson City, MO | $61K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.